Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
9.04
-0.64 (-6.61%)
Aug 20, 2026, 1:45 PM EDT - Market open
Arvinas Market Cap
Arvinas has a market cap or net worth of $591.09 million as of August 20, 2026. Its market cap has increased by 12.76% in one year.
Market Cap
591.09M
Enterprise Value
31.19M
1-Year Change
12.76%
Ranking
Category
Stock Price
$9.04
ChartMarket Cap Chart
Since September 27, 2018, Arvinas's market cap has increased from $516.15M to $591.09M, an increase of 14.52%. That is a compound annual growth rate of 1.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 591.09M | -22.40% |
| Dec 31, 2025 | 761.70M | -42.17% |
| Dec 31, 2024 | 1.32B | -52.94% |
| Dec 29, 2023 | 2.80B | 53.71% |
| Dec 30, 2022 | 1.82B | -58.07% |
| Dec 31, 2021 | 4.34B | 6.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nuvectis Pharma | 621.66M |
| ARS Pharmaceuticals | 620.55M |
| Assembly Biosciences | 611.02M |
| MiMedx Group | 610.74M |
| Autolus Therapeutics | 606.85M |
| CorMedix | 597.83M |
| Altimmune | 583.55M |
| Prelude Therapeutics | 579.86M |